Considerations for bioanalytical characterization and batch release of COVID-19 vaccines
Abstract The COVID-19 pandemic has prompted hundreds of laboratories around the world to employ traditional as well as novel technologies to develop vaccines against SARS-CoV-2. The hallmarks of a successful vaccine are safety and efficacy. Analytical evaluation methods, that can ensure the high qua...
Guardado en:
Autores principales: | Gautam Sanyal, Anna Särnefält, Arun Kumar |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5f6edf1c7a8e454ca1b8e855c1504b98 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Unique features of a recombinant haemagglutinin influenza vaccine that influence vaccine performance
por: Arun B. Arunachalam, et al.
Publicado: (2021) -
Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation
por: Sarah Kreps, et al.
Publicado: (2021) -
Therapeutic vaccines for allergic disease
por: Danuta Gutowska-Owsiak, et al.
Publicado: (2017) -
Strategy for COVID-19 vaccination in India: the country with the second highest population and number of cases
por: Velayudhan Mohan Kumar, et al.
Publicado: (2021) -
Intradermal vaccination of live attenuated influenza vaccine protects mice against homologous and heterologous influenza challenges
por: Andrew Chak-Yiu Lee, et al.
Publicado: (2021)